Blue Trust Inc. Has $165,000 Stake in Molina Healthcare, Inc. (NYSE:MOH)

Blue Trust Inc. boosted its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 84.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 479 shares of the company’s stock after purchasing an additional 220 shares during the quarter. Blue Trust Inc.’s holdings in Molina Healthcare were worth $165,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of MOH. Swedbank AB acquired a new stake in Molina Healthcare in the 1st quarter worth about $69,320,000. Jupiter Asset Management Ltd. raised its stake in Molina Healthcare by 434.6% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company’s stock worth $55,181,000 after purchasing an additional 150,890 shares in the last quarter. AQR Capital Management LLC raised its stake in Molina Healthcare by 36.2% in the 2nd quarter. AQR Capital Management LLC now owns 463,537 shares of the company’s stock worth $137,810,000 after purchasing an additional 123,121 shares in the last quarter. Renaissance Technologies LLC raised its stake in Molina Healthcare by 13.3% in the 2nd quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after purchasing an additional 111,154 shares in the last quarter. Finally, Boston Partners raised its stake in Molina Healthcare by 14.8% in the 1st quarter. Boston Partners now owns 798,950 shares of the company’s stock worth $328,101,000 after purchasing an additional 103,245 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on MOH. TD Cowen decreased their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday, July 24th. Wells Fargo & Company raised their target price on shares of Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a report on Monday, August 5th. Truist Financial decreased their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Thursday. Finally, Stephens reissued an “equal weight” rating and issued a $320.00 target price on shares of Molina Healthcare in a report on Thursday, July 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $367.00.

Insider Buying and Selling

In related news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Trading Up 0.6 %

Shares of Molina Healthcare stock opened at $325.54 on Friday. The firm has a market capitalization of $19.08 billion, a PE ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm’s 50 day moving average is $335.23 and its 200 day moving average is $329.72. Molina Healthcare, Inc. has a 1 year low of $272.69 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, topping the consensus estimate of $5.96 by $0.05. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $10.34 billion for the quarter, compared to the consensus estimate of $9.92 billion. During the same period last year, the company earned $5.05 EPS. The firm’s revenue was up 21.0% compared to the same quarter last year. Equities research analysts forecast that Molina Healthcare, Inc. will post 23.5 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.